Related Experiment Video
Updated: Oct 24, 2026

Finite Element Analysis Model for Assessing Expansion Patterns from Surgically Assisted Rapid Palatal Expansion
Published on: October 20, 2023
When Need Exceeds Support: Lower Medicaid Reimbursement for Cleft Orthodontia in High Pediatric Enrollment States
Ronald R McCall1, Ashlie Elver2, John David West1
1Department of Surgery, Plastic Surgery, University of Mississippi Medical Center School of Medicine, Jackson, MS, USA.
Abstract:
ObjectiveTo analyze the association between Medicaid provider reimbursement for cleft lip and palate (CL/P) procedures and state-level economic factors.DesignCross-sectional study of publicly available 2025 state Medicaid provider reimbursement rates associated with CL/P procedures. Statistical analysis compared provider reimbursement and demographic factors.SettingNational sample of Medicaid reimbursement fee schedules.ParticipantsFifty U.S. states utilizing fee-for-service reimbursement.Main Outcome Measure(s)Reimbursement Rates for D8020 (Phase I: Limited Orthodontia, Transitional Dentition) and D8080 (Phase II: Comprehensive Orthodontia, Adolescent Dentition), CPT 42210 (Palatoplasty for Cleft Palate with Bone Graft), Pediatric Population of Medicaid and Children's Health Insurance Program.ResultsD8080 reimbursement was negatively correlated with pediatric Medicaid enrollment (r = -0.375, p = 0.014). Multivariate linear regression predicted D8080 reimbursement, explaining 46.9% of variance (adjusted R2 = 0.41). Higher reimbursement was associated with higher cost of living (β = 0.39, p = 0.007), poverty (β = 0.51, p < 0.001), and Medicaid expansion (β = 0.27, p = 0.041), but lower in states with greater pediatric enrollment (β = -0.53, p < 0.001).ConclusionsMedicaid provider reimbursement for comprehensive orthodontic treatment is independently associated with state socioeconomic characteristics. Reimbursement decreased with higher enrollment. This trend may further limit provider availability for low-income families with existing barriers in access to care. These findings suggest that Medicaid reimbursement may not adequately scale with pediatric beneficiary demand, potentially limiting access to multidisciplinary treatment.